Amivantamab plus chemo is now indicated in locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R ...

IT is World Lung Day this Wednesday. Ahead of it, the Irish Thoracic Society, which is the national body for health ...

Combining screening for lung and kidney cancers – for both of which smoking is a risk factor – could help identify ...

Lung disease affects around 1 in 7 older persons, making it a serious health risk. Among persons 60 years of age and older, ...

Lung cancer is one of the most common and aggressive cancers. Its most characteristic symptoms include coughing, shortness of ...

Lung cancer is the leading cause of cancer-related deaths, and the most common form is a non-small-cell type called adenocarcinoma.

About 40% of Americans will develop a form of cancer at some point in their lifetime, according to the American Cancer ...

The greatest incidence was seen for metastatic, hematological and lung cancer; an increased risk for CVD was seen with chemotherapy.

A new AstraZeneca drug has failed to extend significantly the lives of breast cancer patients in a blow to the company’s ...

Lung cancer is one of the most common and aggressive cancers. Its most characteristic symptoms include coughing, shortness of ...

AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...